11th Conference on International Arbitration and the UN Convention on Contracts for the International Sale of Goods (CISG)

The Conference aims to address the most pressing and recent challenges in international transactions and dispute resolution, offering participants a comprehensive discussion across a broad spectrum of topics. The 11th Conference will be held in a hybrid format. Speakers and a number of attendees will gather in person at Universidad Panamericana, Guadalajara, while remote participants will beContinue reading “11th Conference on International Arbitration and the UN Convention on Contracts for the International Sale of Goods (CISG)”

CISG Advisory Council Opinion No. 22

CISG Advisory Council Opinion No. 22 The seller’s liability for goods infringing intellectual property rights under Article 42 CISG To be cited as: CISG-AC Opinion No. 22, The seller’s liability for goods infringing intellectual property rights under Article 42 CISG, Rapporteur: Dr. David Tebel, rothorn legal, Frankfurt am Main, Germany. Adopted unanimously by the CISGContinue reading “CISG Advisory Council Opinion No. 22”

Decision of the Supreme Court of New York (25 January 2022)

The seller and the buyer had entered into a contract, which they called the “Export Contract”, in two different languages (English and Chinese). “There is nothing in the English text of the Export Contract that speaks to the law governing the purchase transaction or otherwise evinces the parties’ intention to exclude the CISG. In contrast,Continue reading “Decision of the Supreme Court of New York (25 January 2022)”

Some questions about the first decision of the Belgian court in the dispute between AstraZeneca and the European Commission

In the dispute between AstraZeneca and European Commission, the Belgian Court does not mention (in point IV. A. of the Decision) art. 25 of Regulation (EU) 1215/2012 Of the European Parliament and of the Council. This article states that “[i]f the parties, regardless of their domicile, have agreed that a court or the courts ofContinue reading “Some questions about the first decision of the Belgian court in the dispute between AstraZeneca and the European Commission”